Member Info for Chelsea11

Within the context of the funding discussion………….

Prior to joining Scancell, Dr L'Huillier served as CEO and Managing Director of CatalYm GmbH, a pioneering cancer immunotherapy company headquartered in Munich, Germany. At CatalYm, he was instrumental in expanding the Company's investor base and profile, successfully leading oversubscribed Series C and D financing rounds totalling over $200 million. During his tenure, the company successfully progressed the lead programme from Phase 1 to randomized Phase 2b clinical studies across several indications.

I would suggest he knows what he is doing.

Get high-powered binoculars to see Uranus

Neat trick.

VD “ the revenue / milestone payments are years away”

Really? How do you know that?

Dracula, when you walk into the pub, does is go remarkably quiet?

There is also this to think about..........

"The Company currently has five novel mAbs in early-stage development and has the potential to use its unique methodology to identify many more mAbs against glycan targets in the future"

More golden eggs to be laid in the coming months to be fought over by the likes of Genmab?

The Brothers Grimm who pop up on here, won't be able to kill that goose.

Trotsky - a big guff of smoke in an attempt to cover up your shortcomings. Here’s what the company said while the SP was around £1.10.

“ Our recent acquisition of Industrial Vision Systems has been a successful move, it's performing well and we are excited about the opportunity to drive yet more applications into the smart manufacturing space. We have the financial resources to do so and are working on a number of interesting M&A opportunities to build out our presence in this growing vertical.”

It’s there, in black and white, will you still deny the company’s intent to build out smart manufacturing was not clear??

Yes, you will because you’re a pompous know it all, who simply cannot bring themselves to admit they got it wrong.

Having pulled your pants down, that’s me done.

You would reasonably think the up front payment would be at least match the £5.3M from the Oct 22 deal. Possibly up-negotiated given the strengthening relationship.

That is a fantastic boost.

Trotsky - try reading what I'm posting, or ask someone to explain it to you.

Am I contesting any of what you are saying? No I am not. What I'm calling out is that when the company bought IVS, the strategic direction to further acquire in the smart manufacturing sector in future was crystal clear but you failed to see that, repeatedly denied that the company indicated that and even now, continue to do so. Someone with integrity would be owning up and admitting it was a fair cop, however I guess you're one of those people who falsely believe they could not possibly be wrong about anything. We've all met them.

Same is true about you being a last word merchant. You proved that previously, so why don't you go ahead and double underline that while you're at it?

Trotsky - from today’s RNS.

“Having acquired IVS in November 2023, we said we would develop a meaningful presence in the smart manufacturing market and strengthen our offering via a targeted M&A programme”

I fully expect though, that you will still deny how transparently clear this was in your defence of not selling any shares.

As for the future being loss-making? Utter nonsense. That’s like saying because it rained yesterday, it going to rain a week on Friday. You simply don’t know.

Https://www.reuters.com/business/healthcare-pharmaceuticals/roche-acquire-scancellholdings-£8pershare

HAGW!

Should read Scancell have NO relationship with.

Cleaner - nope, not interesting at all.

A 2 year old Scancell RNS and a totally unrelated, internal appointment at a company Scancell have a relationship with.

🙄🙄🙄

No explanation tells me all I need to know.

Results 3rd December will be an interesting read. Not long to wait.

I’m not as confident as some on here, that there will be a mAb update as early as December.

Obvs I hope my view proves pessimistic but early 2025 is my expectation.

Matt - what about it?

Delays and the many possible reasons behind them have been discussed here at length previously. Valid reasons.

Lofas -

In September you said 9p

In October you said 10p

In November you are saying 14p (“said all along 14p” 😂)

Where you going next?

Are you able to explain the point you are trying to make?

It’s transparently clear that many companies will be looking to reduce one of their biggest costs ie. labour. In fact they will be forced to in order to survive.

Logical to think that the smart manufacturing industry might in time benefit from the National Insurance changes announced in the recent Budget. Employers will be seeking cost-cutting efficiencies to re-balance the increasing cost of employees. Some time will need to go by before any difference is seen on the bottom line but the 2 companies acquired to date, could prove to be a shrewd investment. Of course there is competition but a huge market to go after.

Depends how closely you read them and the time taken to check your understanding.

CW. I love em. Especially those that are approaching 2 years old, are nothing to do with the progress of Scancell and contain 7 links to the road to nowhere 😂